您的位置: 首页 > 农业专利 > 详情页

COMPLEX ETHERIC PROCEDURES [3- (1- (1H-IMIDAZOL-4) ETHYL) -2-METHYLPHENYL] METHANOL TO REDUCE THE INTERNAL EYE PRESSURE
专利权人:
ИНК. (US);АЛЛЕРГАН
发明人:
ДИБАС Мохаммед И. (US),ЧОУ Кен (US),ДОНЕЛЛО Джон Е. (US),ГАРСТ Майкл Е. (US),ДЖИЛ Дэниел В. (US),ВАНГ Лиминг (US)
申请号:
RU2013116763/15
公开号:
RU2013116763A
申请日:
2011.09.16
申请国别(地区):
RU
年份:
2014
代理人:
摘要:
1. A method of reducing intraocular pressure in a subject in need of such treatment, comprising administering a therapeutically effective amount of a composition containing a compound of Formula I, its individual enantiomers, its individual diastereoisomers, its hydrates, its solvates, its crystalline forms, its individual isomers, its individual tautomers or a pharmaceutically acceptable salt thereof, wherein R is H or C1-6alkyl; R is H or C1-6alkyl; R is H, C1-6alkyl, heterocycle or aryl; and R is C1-6alkyl, heterocycle or aryl. 2. The method according to claim 1, characterized in that the compound is a compound of Formula II, its individual diastereoisomers, its hydrates, its solvates, its crystalline forms, its individual isomers, its individual tautomers or its pharmaceutically acceptable salt, where R is H or C1-6alkyl; R is H or C1-6alkyl; R is H, C1-6alkyl, heterocycle or aryl; and R is C1-6 alkyl, heterocycle or aryl. 3. The method according to claim 1, characterized in that the compound is a compound of Formula III, its individual diastereoisomers, its hydrates, its solvates, its crystalline forms, its individual isomers, its individual tautomers or its pharmaceutically acceptable salt, where R is H or C1-6alkyl; R is H or C1-6alkyl; R is H, C1-6alkyl, heterocycle or aryl; and R is C1-6 alkyl, heterocycle or aryl. 4. The method according to claim 2, characterized in that R is C1-6alkyl, R is C1-6alkyl, R is H, and R is C1-6alkyl. The method according to claim 2, characterized in that R is methyl, R is methyl, R is H, and R is C1-6alkyl. The method according to claim 2, characterized in that the connection in1. Способ снижения внутриглазного давления у субъекта, нуждающегося в таком лечении, включающий введение терапевтически эффективного количества композиции, содержащей соединение Формулы I, его отдельные энантиомеры, его отдельные диастереоизомеры, его гидраты, его сольваты, его кристаллические формы, его отдельные изомеры, его отдельные таутомеры или ег
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充